Steady Q1 Seen For Sun Pharma
  • WebDesk BTVI
  • Aug 13 2019

Sun Pharma is expected to post a good June quarter results, with net profit seen up 6.5 per cent year-no-year at Rs 1,046 crore, revenue up 12 per cent at Rs 8,122 crore, EBITDA seen up 17.5 per cent at Rs 1,788 crore and EBITDA margin seen at 22 per cent vs 21 per cent in the year-ago period.